Portage, MI, United States of America

Robert G Ankenbauer



 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Kalamazoo, MI (US) (2016)
  • Portage, MI (US) (2014 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Robert G Ankenbauer: A Pioneer in Vaccination Technology

Introduction: Robert G Ankenbauer, based in Portage, Michigan, has made significant contributions to the field of veterinary medicine through his innovative work on vaccinations. With a remarkable portfolio of 10 patents, he is at the forefront of combating porcine reproductive and respiratory syndrome (PRRS) virus, a major concern for the swine industry.

Latest Patents: Ankenbauer's latest patents focus on developing an effective vaccination strategy against the PRRS virus prior to weaning. His invention provides isolated polynucleotide molecules that encode an infectious RNA sequence for a genetically-modified North American PRRS virus. The patents also detail methods to create these vaccines, along with related polypeptides, polynucleotides, and diagnostic kits. These diagnostic tools are essential for distinguishing between naturally infected and vaccinated animals, thus enhancing disease management in livestock.

Career Highlights: Ankenbauer has built a reputable career in the biotechnology and pharmaceutical sectors. Notably, he has worked with Zoetis Services LLC and Zoetis LLC, two prominent companies specializing in animal health products. His innovations have not only improved animal health but have also contributed to the economic sustainability of the agricultural sector.

Collaborations: Throughout his career, Ankenbauer has collaborated with accomplished professionals in the field, including Jay Gregory Calvert and Jacqueline Gayle Marx. These partnerships have played a crucial role in advancing research and development efforts in vaccination technologies.

Conclusion: Robert G Ankenbauer's contributions to vaccine innovation, particularly in relation to the PRRS virus, highlight his dedication to improving animal health and welfare. His ten patents reflect not only his inventive spirit but also his commitment to collaborating and addressing critical challenges in veterinary science. As the demand for effective livestock management solutions continues to rise, Ankenbauer's work will undoubtedly remain influential in shaping the future of animal health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…